IP Verse

Novartis Gene Therapies, Inc. et al. v. Genzyme Corporation et al. - IPR2023-00609

Explore the PTAB proceeding IPR2023-00609 filed by Novartis Gene Therapies, Inc. et al. against Genzyme Corporation et al. on Feb 22, 2023. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2023-00609
Filing Date
Feb 22, 2023
Petitioner
Novartis Gene Therapies, Inc. et al.
Respondent
Genzyme Corporation et al.
Status
Institution Denied
Respondent Application Number
12661553
Respondent Tech Center
1600
Respondent Patent Number
9051542
Institution Decision Date
Aug 30, 2023
Termination Date
Aug 30, 2023

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number IPR2023-00609.

TypeName
Petitioner CounselLivingstone, Johnet al
Respondent CounselAntons, Amandaet al

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.